Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Chin 2015 US Patent

From Bioblast
Publications in the MiPMap
Chin MT, Chien WM, Dinca A (2015) Modified tafazzin proteins and methods of making and using the same. US Patent US20150203827 A1.

Β» Open Access

Chin MT, Chien WM, Dinca A (2015) US Patent

Abstract: Fusion proteins comprising a tafazzin peptide and a cellular permeability peptide are disclosed. The tafazzin peptide may be coupled to the permeability peptide through a polypeptide linker. Methods of making and using the fusion proteins are also disclosed. For example, the disclosed fusion proteins may be used to treat a patient having a disorder associated with a tafazzin deficiency or a remodeled cardiolipin deficiency (e.g., Barth syndrome). Additionally, the disclosed fusion proteins may be used in prophylaxis against developing a disorder associated with a tafazzin deficiency or a remodeled cardiolipin deficiency in a patient at risk of developing such a disorder.

β€’ Bioblast editor: Kandolf G


Labels: MiParea: Respiration 


Organism: Mouse  Tissue;cell: Skeletal muscle  Preparation: Permeabilized tissue 


Coupling state: OXPHOS  Pathway: N, S, CIV  HRR: Oxygraph-2k 

Labels